Stocktoria
NATURES SUNSHINE PRODUCTS INC NATR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2009-06-25
NATURES SUNSHINE PRODUCTS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 72.4% | 71.5% | 72.1% | 71.0% | 74.0% |
| Operating margin | 5.2% | 4.4% | 4.2% | 3.9% | 7.8% |
| Net margin | 4.1% | 1.7% | 3.4% | -0.1% | — |
| FCF margin | 6.0% | 3.2% | 6.9% | -1.6% | 6.3% |
| Return on assets | 7.5% | 3.2% | 6.0% | -0.2% | — |
| Return on equity | 12.1% | 4.8% | 9.4% | -0.3% | — |
| Debt / equity | — | — | 0.00× | 0.01× | 0.01× |
| Current ratio | 2.28 | 2.44 | 2.16 | 2.28 | 2.15 |
| Revenue growth | 5.7% | 2.0% | 5.5% | -5.0% | 15.3% |
Source: SEC EDGAR filings · CIK 0000275053 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.